Current Funding Opportunities
Through our research program, Komen awards grants to support cutting-edge breast cancer research that will provide the greatest benefit to patients. We’re focused on conquering metastatic and aggressive breast cancers, advancing personalized breast care and eliminating breast cancer disparities and inequities. Our goal is to improve breast health care and outcomes for everyone and save lives.
Each year, we release Request for Applications (RFA) to communicate which grant mechanisms and scientific focus areas are available for funding. The types of mechanisms and the scientific focus areas may vary from year to year. Check out our latest research funding opportunities below!
2024-2025 (FY25) Letter of Intent Announcement – Limited Submission Opportunities
• Letter of Intent (LOI) Announcement Release Date: June 12, 2024
• Institution Opt in Deadline: June 26, 2024
• LOI Submission Deadline: August 7, 2024 at 1:00pm ET
• Invitation to submit an Application: August 21, 2024 at 1:00pm ET
Limited Submission & Nomination Process: Each institution may submit up to two nominees to apply for each funding opportunity, if at least one of the two nominees identifies as someone from groups shown to be historically minoritized and marginalized in biomedical research from National Science Foundation data, including Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders, and individuals with disabilities, as well as individuals from disadvantaged backgrounds. Institutions must respond to missiongrantsadmin@komen.org by June 26, 2024, to indicate that they are opting-in to the institutional nomination process. Prior to the LOI submission deadline (August 7, 2024), institutions that have opted in must provide Komen with the name(s) and email address(es) of the 1 or 2 applicants (based on eligibility requirements) being nominated to apply for funding. Institutions will receive a link(s) that their nominee(s) may use to submit the required documents for LOI submission.
COMING SOON! Request for Applications for A Supplement to Promote Inclusion for Research Excellence (ASPIRE) Grants
Komen Review Process
Susan G. Komen® utilizes a multi-step approach to grant application and review that first requires submission of a Letter of Intent and upon invitation only, submission of an Application.
Applicants/PIs will be notified of Letter of Intent review decisions via email. Applicants/PIs invited to submit an Application will then be granted access to the Application site in proposalCENTRAL.
All institutions must agree to adhere to Komen’s Policies and Procedures for Research and Training Grants. A copy of the latest version of these awards is found with the other documents for the LOI in proposalCENTRAL.
Clinical Trials We Are Funding
See what types of clinical trials Komen research has supported.
Bringing the Patient Voice to Research
Learn how breast cancer survivors and advocates are involved in our scientific research.
TOOLS & RESOURCES